Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

5:50 PM ET Form 4
Insider Selling First Northern Community Bancorp FNRN

First Northern Community Bancorp Insider Mark C. Schulze Sells $83.3K of Stock

Mark C. Schulze sold 5,000 shares of First Northern Community Bancorp at $16.63 to $16.75 a share (average $16.66) in 3 transactions, worth $83.3K in total between Nov 9, 2026 and Nov 11, 2026. Shares held after the trade: 722,421 (-0.4%).

Value
$83.3K
Shares
5,000
Average price
$16.66
Holding change
-0.4%
Trade date
Nov 9, 2026 to Nov 11, 2026
5:48 PM ET Form 4
Insider Selling Samsara Inc. IOT

Samsara Insider John Bicket Sells $9.78M of Stock

John Bicket sold 235,028 shares of Samsara Inc. at $41.17 to $42.09 a share (average $41.62) in 12 transactions, worth $9.78M in total between Nov 10, 2026 and Nov 12, 2026. Shares held after the trade: 89,900 (-1.9%).

Value
$9.78M
Shares
235,028
Average price
$41.62
Holding change
-1.9%
Trade date
Nov 10, 2026 to Nov 12, 2026
5:48 PM ET Form 4
Insider Buying Zai Lab Ltd ZLAB

Zai Lab Director Richard Gaynor Buys $33.4K of Stock

Richard Gaynor, Director, bought 1,228 shares of Zai Lab Ltd at $27.19 a share, worth $33.4K in total on Nov 10, 2026. Shares held after the trade: 81,965 (+1.5%).

Value
$33.4K
Shares
1,228
Price
$27.19
Role
Director
Holding change
+1.5%
Trade date
Nov 10, 2026
5:45 PM ET Form 4
Insider Buying Claritev Corp CTEV

Claritev Pres., CEO & Executive Chair Travis Dalton Buys $150K of Stock

Travis Dalton, Pres., CEO & Executive Chair, bought 5,110 shares of Claritev Corp at $29.34 a share, worth $150K in total on Nov 11, 2026. Shares held after the trade: 57,432 (+9.8%).

Value
$150K
Shares
5,110
Price
$29.34
Role
Pres., CEO & Executive Chair
Holding change
+9.8%
Trade date
Nov 11, 2026
5:45 PM ET Form 4
Insider Selling Flexsteel Industries Inc FLXS

Flexsteel Industries Chief Information Officer Michael Joseph McClaflin Sells $226K of Stock

Michael Joseph McClaflin, Chief Information Officer, sold 3,000 shares of Flexsteel Industries Inc at $75.20 to $75.62 a share (average $75.44) in 3 transactions, worth $226K in total between Nov 11, 2026 and Nov 12, 2026. Shares held after the trade: 33,026 (-2.9%).

Value
$226K
Shares
3,000
Average price
$75.44
Role
Chief Information Officer
Holding change
-2.9%
Trade date
Nov 11, 2026 to Nov 12, 2026
5:45 PM ET Form 4
Insider Selling Morningstar, Inc. MORN

Morningstar Executive Chairman Joseph D. Mansueto Sells $1.79M of Stock

Joseph D. Mansueto, Executive Chairman, sold 7,250 shares of Morningstar, Inc. at $246.75 to $248.46 a share (average $247.30) in 3 transactions, worth $1.79M in total on Nov 13, 2026. Shares held after the trade: 8,558,044 (-0.0%).

Value
$1.79M
Shares
7,250
Average price
$247.30
Role
Executive Chairman
Holding change
-0.0%
Trade date
Nov 13, 2026
5:41 PM ET Form 4
Insider Selling Magnite, Inc. MGNI

Magnite Insider Diane Yu Sells $583K of Stock

Diane Yu sold 20,000 shares of Magnite, Inc. at $29.17 a share, worth $583K in total on Nov 12, 2026. Shares held after the trade: 61,279 (-24.6%).

Value
$583K
Shares
20,000
Price
$29.17
Holding change
-24.6%
Trade date
Nov 12, 2026
5:41 PM ET Form 4
Insider Selling Molina Healthcare, Inc. MOH

Molina Healthcare Insider Dale B. Wolf Sells $330K of Stock

Dale B. Wolf sold 1,600 shares of Molina Healthcare, Inc. at $206.12 a share, worth $330K in total on Nov 13, 2026. Shares held after the trade: 14,337 (-10.0%).

Value
$330K
Shares
1,600
Price
$206.12
Holding change
-10.0%
Trade date
Nov 13, 2026
5:40 PM ET Form 4
Insider Selling Veradermics, Inc MANE

Veradermics Director Patrick G. Enright Sells $75.2M of Stock

Patrick G. Enright, Director, sold 500,000 shares of Veradermics, Inc at $150.38 a share, worth $75.2M in total on Nov 11, 2026. Shares held after the trade: 1,803,474 (-12.2%).

Value
$75.2M
Shares
500,000
Average price
$150.38
Role
Director
Holding change
-12.2%
Trade date
Nov 11, 2026
5:38 PM ET Form 4
Insider Selling Molina Healthcare, Inc. MOH

Molina Healthcare Insider Richard M. Schapiro Sells $159K of Stock

Richard M. Schapiro sold 782 shares of Molina Healthcare, Inc. at $203.94 a share, worth $159K in total on Nov 10, 2026. Shares held after the trade: 11,833 (-6.2%).

Value
$159K
Shares
782
Price
$203.94
Holding change
-6.2%
Trade date
Nov 10, 2026
5:38 PM ET Form 4
Insider Buying Upstart Holdings, Inc. UPST

Upstart Holdings CEO Paul Gu Buys $1.03M of Stock

Paul Gu, CEO, bought 50,000 shares of Upstart Holdings, Inc. at $20.57 a share, worth $1.03M in total on Nov 11, 2026. Shares held after the trade: 180,000 (+38.5%).

Value
$1.03M
Shares
50,000
Price
$20.57
Role
CEO
Holding change
+38.5%
Trade date
Nov 11, 2026
5:37 PM ET Form 4
Insider Selling Molina Healthcare, Inc. MOH

Molina Healthcare CLO Jeff D. Barlow Sells $1.62M of Stock

Jeff D. Barlow, CLO, sold 8,000 shares of Molina Healthcare, Inc. at $203.07 a share, worth $1.62M in total on Nov 10, 2026. Shares held after the trade: 59,313 (-11.9%).

Value
$1.62M
Shares
8,000
Price
$203.07
Role
CLO
Holding change
-11.9%
Trade date
Nov 10, 2026
5:35 PM ET Form 4
Insider Selling Jack in the Box Inc JACK

Jack in the Box Exec Chairman & Interim CEO Mark James King Sells $113K of Stock

Mark James King, Exec Chairman & Interim CEO, sold 7,977 shares of Jack in the Box Inc at $14.11 a share, worth $113K in total on Nov 13, 2026. Shares held after the trade: 161,288 (-4.7%).

Value
$113K
Shares
7,977
Price
$14.11
Role
Exec Chairman & Interim CEO
Holding change
-4.7%
Trade date
Nov 13, 2026
5:34 PM ET Form 4
Insider Selling Veradermics, Inc MANE

Veradermics 10% Owner Longitude Capital Partners V LLC Sells $75.2M of Stock

Longitude Capital Partners V LLC, 10% Owner, sold 500,000 shares of Veradermics, Inc at $150.38 a share, worth $75.2M in total on Nov 11, 2026. Shares held after the trade: 1,803,474 (-12.2%).

Value
$75.2M
Shares
500,000
Average price
$150.38
Role
10% Owner
Holding change
-12.2%
Trade date
Nov 11, 2026
5:34 PM ET Form 4
Insider Buying Neonc Technologies Holdings, Inc. NTHI

Neonc Technologies Holdings CEO, President Amir F. Heshmatpour Buys $151K of Stock

Amir F. Heshmatpour, CEO, President, bought 30,000 shares of Neonc Technologies Holdings, Inc. at $5.02 a share, worth $151K in total on Nov 13, 2026. Shares held after the trade: 3,353,000 (+0.9%).

Value
$151K
Shares
30,000
Price
$5.02
Role
CEO, President
Holding change
+0.9%
Trade date
Nov 13, 2026
5:34 PM ET Form 4
Insider Selling Sinclair, Inc. SBGI

Sinclair COO & President of Local Media Robert Weisbord Sells $150K of Stock

Robert Weisbord, COO & President of Local Media, sold 10,000 shares of Sinclair, Inc. at $15.02 a share, worth $150K in total on Nov 11, 2026. Shares held after the trade: 289,408 (-3.3%).

Value
$150K
Shares
10,000
Price
$15.02
Role
COO & President of Local Media
Holding change
-3.3%
Trade date
Nov 11, 2026
5:33 PM ET Form 4
Insider Buying Global Partners LP GLP

Global Partners Insider Global GP LLC Buys $442K of Stock

Global GP LLC bought 10,000 shares of Global Partners LP at $43.79 to $44.56 a share (average $44.25) in 3 transactions, worth $442K in total between Nov 11, 2026 and Nov 13, 2026. Shares held after the trade: 181,584 (+1.4%).

Value
$442K
Shares
10,000
Average price
$44.25
Holding change
+1.4%
Trade date
Nov 11, 2026 to Nov 13, 2026
5:31 PM ET 10-Q
Financial Results Alset Inc. AEI

Alset Q3 2026 Results: Net Income $5.17M, Up 242.0% YoY

Alset Inc. reported a net loss of $6.7 million for the nine months ended September 30, 2026, compared to a $16.4 million loss in the prior year period. Total revenue decreased slightly to $2.9 million, while the company recognized a significant $6.1 million gain from the deconsolidation of ESYN during the third quarter.

Key figure
Net income $5.17M · +242.0% YoY
5:30 PM ET 10-Q
Financial Results Perpetua Resources Corp. PPTA

Perpetua Resources Q3 2026 Results: Net Loss of $79.2M, Loss Widens

Perpetua Resources Corp. reported a significant increase in net loss to $225.3 million for the nine months ended September 30, 2026, primarily driven by a surge in exploration and pre-development expenses. The company's cash position decreased to $443.4 million as it continues to invest in the Stibnite Gold Project and awaits full project financing.

Key figure
Net loss $79.2M
5:29 PM ET Form 4
Insider Selling Bristow Group Inc. VTOL

Bristow Group Insider Solus Alternative Asset Management LP Sells $2.98M of Stock

Solus Alternative Asset Management LP sold 73,600 shares of Bristow Group Inc. at $40.37 to $41.45 a share (average $40.44) in 4 transactions, worth $2.98M in total between Nov 10, 2026 and Nov 13, 2026. Shares held after the trade: 2,766,836 (-0.2%).

Value
$2.98M
Shares
73,600
Average price
$40.44
Holding change
-0.2%
Trade date
Nov 10, 2026 to Nov 13, 2026
5:29 PM ET 10-Q
Financial Results TPG Twin Brook Capital Income Fund

TPG Twin Brook Capital Income Fund Q3 2026 Results: Net Income $66.1M, Up 64.2% YoY

TPG Twin Brook Capital Income Fund reported total investment income of $359.4 million for the nine months ended September 30, 2026, up from $288.6 million in the prior year period. Net assets grew to $2.79 billion as of September 30, 2026, driven by $405.4 million in net capital share transactions and $187.9 million in net increase in net assets from operations.

Key figure
Net income $66.1M · +64.2% YoY
5:29 PM ET 10-Q
Financial Results Dragonfly Energy Holdings Corp. DFLI

Dragonfly Energy Holdings Q3 2026 Results: Net Loss of $5.54M, Loss Narrows

Dragonfly Energy reported a net loss of $16.6 million for the nine months ended September 30, 2026, compared to a $24.9 million loss in the prior year period. Net sales decreased to $35.0 million from $45.6 million year-over-year, while the company's cash position significantly declined to $1.9 million as of September 30, 2026.

Key figure
Net loss $5.54M
5:29 PM ET 10-Q
Financial Results Syntec Optics Holdings, Inc. OPTX

Syntec Optics Holdings Q3 2026 Results: Turns Profitable, Net Income $247K

Syntec Optics reported net sales of $23.3 million for the nine months ended September 30, 2026, a 13.4% increase over the prior year. Despite the revenue growth, the company recorded a net loss of $395,046 for the period, though this was a significant improvement from the $1.45 million loss in 2025. The company's cash position strengthened substantially to $14.4 million following $23 million in gross proceeds from a common stock issuance.

Key figure
Net income $247K
5:29 PM ET 8-K
Investor Presentation Macrogenics Inc MGNX

Macrogenics Investor Presentation

MacroGenics, Inc. made available an updated corporate presentation on its website and as an exhibit to its 8-K filing. The presentation provides updated clinical program details and strategic priorities for the company's therapeutic candidates. The filing serves as a Regulation FD disclosure to ensure the updated information is available to the public and investors.

5:28 PM ET 10-Q
Financial Results Canary XRP ETF XRPC

Canary XRP ETF Q3 2026 Results: Net Income $104M

As of September 30, 2026, the Canary XRP ETF held $368.8 million in XRP, representing a net asset value of $15.79 per share. For the nine months ended September 30, 2026, the Trust reported a net decrease in net assets from operations of $60.5 million, primarily driven by $50.2 million in unrealized depreciation and $9.2 million in realized losses on its crypto currency investments.

Key figure
Net income $104M
5:28 PM ET 10-Q
Financial Results Eightco Holdings Inc. ORBS

Eightco Holdings Q3 2026 Results: Turns Profitable, Net Income $54.4M

Eightco Holdings Inc. reported a significant shift in its business model towards a Digital Asset Treasury Strategy, with total assets increasing to $446.3 million as of September 30, 2026, primarily driven by $205.4 million in digital assets and $82.6 million in stablecoins. However, the company experienced a sharp decline in revenues to $9.7 million for the nine months ended September 30, 2026, compared to $22.8 million in the prior year, resulting in an operating loss of $25.9 million.

Key figure
Net income $54.4M
5:28 PM ET 10-Q
Financial Results Apollo Asset Backed Credit Co LLC

Apollo Asset Backed Credit Co Q3 2026 Results: Net Income $18M, Down 16.3% YoY

Apollo Asset Backed Credit Company LLC reported total net assets of approximately $1.98 billion as of September 30, 2026, across its Series I and Series II interests. The company, an emerging growth company, saw its total assets grow to $2.52 billion from $1.89 billion at the end of 2025, driven primarily by an increase in investments at fair value.

Key figure
Net income $18M · -16.3% YoY
5:28 PM ET 8-K
Financial Results Tempest Therapeutics, Inc. TPST

Tempest Therapeutics Financial Results

Tempest Therapeutics reported third quarter 2026 financial results and provided a business update on its in vivo CAR-T pipeline, including the lead candidate TPST-4903. During the quarter, the company exercised its option for an exclusive license to Senlang's CD7-targeted platform and secured access to capital through a $50 million equity line of credit and a $2.5 million private placement.

“The third quarter marked a period of meaningful progress in the advancement of two next-generation in vivo CAR-T platforms with the potential to transform treatment across multiple diseases.”

Matt Angel, Ph.D., president and chief executive officer of Tempest

“We made important strides in expanding our pipeline and strengthening our position in the rapidly evolving in vivo CAR-T landscape through our strategic collaboration with Senlang by obtaining exclusive license rights to our clinical-stage BCMA/GPRC5D in vivo CAR-T candidate TPST-4903, while securing access to additional capital to support our development priorities.”

Matt Angel, Ph.D., president and chief executive officer of Tempest
5:28 PM ET 8-K
Financial Results BeyondSpring Inc. BYSI

BeyondSpring Financial Results

BeyondSpring reported Q3 2026 financial results and highlighted that the FDA granted Fast Track designation for Plinabulin in combination with docetaxel for certain NSCLC patients. The company also completed a strategic transaction with Biolin to fund approximately half of the enrollment for the Phase 3 DUBLIN-4 trial.

Term
Q3 2026

“The FDA’s Fast Track designation underscores the significant unmet need for new treatment options for NSCLC patients without AGA and progressing after immune checkpoint inhibitor therapy, where docetaxel is still the standard of care.”

Min Qiu, Chief Executive Officer of BeyondSpring

“With an FDA-aligned Phase 3 design and a strategic transaction with Biolin to support approximately half of DUBLIN-4’s planned 442-patient enrollment, generating quality data from China, we remain focused on advancing the study toward its prespecified interim analysis at 221 progression-free survival events.”

Min Qiu, Chief Executive Officer of BeyondSpring
5:27 PM ET 10-Q
Financial Results Awaysis Capital, Inc. AWCA

Awaysis Capital Q1 2026 Results: Net Loss of $603K, Loss Narrows

Awaysis Capital, Inc. reported a net loss of $602,539 for the three months ended September 30, 2026, compared to a net loss of $651,548 in the prior year period. Revenue increased to $164,671 from $95,198, while the company continued to focus on its vacation rental and real estate development activities in Belize.

Key figure
Net loss $603K

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.